Articles

• Select this article
  • W E Farrell,
  • D J Simpson,
  • S J Frost,
  • and R N Clayton

  Methylation mechanisms in pituitary tumorigenesis.

  Endocr Relat Cancer 6 (4) 437-47, doi:10.1677/erc.0.0060437
  • Abstract
  • Full Text (PDF)
• Select this article
  • A A Pannett and
  • R V Thakker

  Multiple endocrine neoplasia type 1.

  Endocr Relat Cancer 6 (4) 449-73, doi:10.1677/erc.0.0060449
  • Abstract
  • Full Text (PDF)
• • J R Davis,
  • P R Lowenstein,
  • A S McNeilly,
  • and M G Castro

  Gene therapy for pituitary tumours.

  Endocr Relat Cancer 6 (4) 475-81, doi:10.1677/erc.0.0060475
  • Full Text (PDF)
• Select this article
  • A Manni

  Hormonal approaches to the chemoprevention of endocrine-dependent tumors.

  Endocr Relat Cancer 6 (4) 483-5, doi:10.1677/erc.0.0060483
  • Abstract
  • Full Text (PDF)
• Select this article
  • M D Sadar,
  • M Hussain,
  • and N Bruchovsky

  Prostate cancer: molecular biology of early progression to androgen independence.

  Endocr Relat Cancer 6 (4) 487-502, doi:10.1677/erc.0.0060487
  • Abstract
  • Full Text (PDF)
• Select this article
  • P A Abrahamsson

  Neuroendocrine cells in tumour growth of the prostate.

  Endocr Relat Cancer 6 (4) 503-19, doi:10.1677/erc.0.0060503
  • Abstract
  • Full Text (PDF)
• • R Eeles and
  • L Kadouri

  BRCA1/2 carriers and endocrine risk modifiers.

  Endocr Relat Cancer 6 (4) 521-8, doi:10.1677/erc.0.0060521
  • Full Text (PDF)
• Select this article
  • M Seki,
  • K Nomura,
  • D Hirohara,
  • M Kanazawa,
  • T Sawada,
  • K Takasaki,
  • and H Demura

  Changes in neoplastic cell features and sensitivity to mitotane during mitotane-induced remission in a patient with recurrent, metastatic adrenocortical carcinoma.

  Endocr Relat Cancer 6 (4) 529-33, doi:10.1677/erc.0.0060529
  • Abstract
  • Full Text (PDF)